1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,098 | 0,134 | 06.09. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | hVIVO PLC - Notice of Results | - | RNS | ||
| Mo | hVIVO appoints Avacta Chair Shaun Chilton to lead board | 1 | Alliance News | ||
| Mo | hVIVO PLC - Appointment of Non-Executive Chair | - | RNS | ||
| 29.07. | hVIVO PLC - Proposed appointment of Chair | - | RNS | ||
| 22.07. | TRADING UPDATES & EARNINGS: hVIVO expects interim revenue decline | 2 | Alliance News | ||
| HVIVO Aktie jetzt für 0€ handeln | |||||
| 22.07. | hVIVO PLC - H1 Trading update | - | RNS | ||
| 18.07. | hVIVO PLC - Directorate Change | - | RNS | ||
| 09.07. | hVIVO PLC - Notice of Trading Update | - | RNS | ||
| 30.06. | hVivo reports positive results from its largest lab contract to date | 1 | Sharecast | ||
| 30.06. | hVIVO reports positive results from Cidara's Phase 2b influenza study | 3 | Investing.com | ||
| 30.06. | hVIVO PLC - Positive results from client Phase 2b field study | - | RNS | ||
| 05.06. | hVIVO PLC - Result of AGM | - | RNS | ||
| 02.06. | DIRECTOR DEALINGS: hVIVO CEO buys shares; Investec execs sell stock | 2 | Alliance News | ||
| 02.06. | hVIVO PLC - Director/PDMR Shareholding | - | RNS | ||
| 30.05. | hVIVO stock plunges after contract cancellations in 'depressed' market | 1 | Alliance News | ||
| 30.05. | Hvivo shares tank after contract cancellations | 4 | Shares | ||
| 30.05. | AIM WINNERS & LOSERS: hVIVO shares dive on contract cancellations | 1 | Alliance News | ||
| 30.05. | Hvivo client cancels 'significant' HCT trial contract | 1 | Sharecast | ||
| 30.05. | hVIVO PLC - Trading update | - | RNS | ||
| 29.05. | hVIVO PLC - Appointment of Independent Non-Executive Director | - | RNS |
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 0,493 | +9,54 % | Plus Therapeutics stock rating upgraded to Buy by D. Boral Capital | ||
| LIFEWARD | 0,532 | -4,44 % | Lifeward Ltd.: Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
| JD HEALTH | 7,150 | +1,42 % | Aktie von JD Health kann Vortagsniveau nicht halten (6,80 €) | Der Anteilsschein von JD Health notiert am Dienstag etwas leichter. Das Wertpapier kostete zuletzt 6,80 Euro. Für die JD Health-Aktie steht gegenwärtig ein Verlust von 3,55 Prozent zu Buche. Die Aktie... ► Artikel lesen | |
| EKSO BIONICS | 3,990 | -1,72 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 4,740 | -3,66 % | Imunon, Inc.: IMUNON Successfully Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement | LAWRENCEVILLE, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its DNA-mediated immunotherapy, today announced that the Company... ► Artikel lesen | |
| BIOCEPT | 7,200 | 0,00 % | GlaxoSmithKline Bioc: Gewinn im zweiten Quartal bei 5,9 Mio. EGP | ||
| ROCKWELL MEDICAL | 1,464 | +6,16 % | ROCKWELL MEDICAL, INC. - S-8, Securities to be offered to employees in employee benefit plans | ||
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| VIRIDIAN THERAPEUTICS | 15,620 | -2,25 % | These Analysts Revise Their Forecasts On Viridian Therapeutics Following Q2 Results | ||
| SINTX TECHNOLOGIES | 5,500 | +25,57 % | Sintx Technologies, Inc. - 8-K, Current Report | ||
| AETHLON MEDICAL | 1,430 | -100,00 % | Aethlon Medical Prices $4.5 Mln Public Offering Of Common Stock And Warrants | ||
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 28.08.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 28.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 28.08.2025.ISIN NameAU000000DHG9 DOMAIN... ► Artikel lesen | |
| SAVARIA | 12,800 | 0,00 % | Dividendenbekanntmachungen (29.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACNB CORPORATION US0008681092 0,34 USD 0,2911 EUR ADVANCED DRAINAGE SYSTEMS INC US00790R1041 0,18 USD 0,1541 EUR AEBI SCHMIDT HOLDING... ► Artikel lesen | |
| NEURONETICS | 2,725 | -1,09 % | Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve... ► Artikel lesen | |
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report |
HVIVO PLC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,096 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HVIVO PLC finden Sie auf Wallstreet Online.